Peer-reviewed veterinary case report
MicroRNAs in blood do not differ in dogs with chronic hepatitis
By Tinoco-Nájera, Adrián et al.·Published in American journal of veterinary research·2026·Department of Small Animal Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Serum microRNAs 122, 1275, 21, 222, and 181A are not differentially expressed in dogs with idiopathic or copper-associated chronic hepatitis.
- Species:
- dog
Plain-English summary
A group of dogs with chronic hepatitis (liver inflammation) was studied to see if certain microRNAs could help identify the type of hepatitis they had, either idiopathic (unknown cause) or copper-associated. The study included 18 dogs with idiopathic hepatitis, 14 with copper-associated hepatitis, and 42 healthy dogs. Unfortunately, the researchers found that the microRNAs tested did not help distinguish between the two types of hepatitis, although some were linked to liver damage. This means that these specific microRNAs aren't useful for diagnosing the type of chronic hepatitis in dogs.
People also search for: dog chronic hepatitis symptoms · dog liver disease treatment · copper-associated hepatitis in dogs
Abstract
OBJECTIVE: To determine whether microRNAs 122, 1275, 21, 222, and 181A serve as noninvasive biomarkers of canine chronic hepatitis (CH); can distinguish between dogs with idiopathic CH (iCH) and copper-associated CH (CuCH); and correlate with serum ALT activity, grade of inflammation, fibrosis, and degree of copper accumulation. METHODS: From May 2019 through October 2023, dogs with CH, histologically characterized as either iCH or CuCH, and healthy control (HC) dogs without liver biopsies were enrolled in this prospective uncontrolled study. Serum samples were collected, and serum microRNAs were quantified by real-time quantitative PCR. Differences in gene fold expression between groups were calculated. Correlations between microRNA gene fold expression and serum ALT, hepatic copper quantification, grade of necroinflammatory activity, fibrosis, and histological copper score were assessed. RESULTS: A total of 18 dogs with iCH, 14 dogs with CuCH, and 42 HC dogs were enrolled. No differences between iCH and CuCH dogs were observed for any microRNA. Differences between HC and overall CH dogs were observed for microRNAs 122, 1275, and 21. Positive correlations with serum ALT activity between microRNAs 122 and 21 were observed. CONCLUSIONS: None of the studied microRNAs were able to differentiate iCH from CuCH and only correlated with ALT activity. Serum microRNAs 122, 1275, and 21 appear to be nonspecific makers of hepatocellular injury. CLINICAL RELEVANCE: Our results do not support the utility of these microRNAs as markers for distinguishing between iCH and CuCH in dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41072468/